[go: up one dir, main page]

HUT59318A - Process for stabilizing k2p pro t-pa - Google Patents

Process for stabilizing k2p pro t-pa

Info

Publication number
HUT59318A
HUT59318A HU912738A HU273890A HUT59318A HU T59318 A HUT59318 A HU T59318A HU 912738 A HU912738 A HU 912738A HU 273890 A HU273890 A HU 273890A HU T59318 A HUT59318 A HU T59318A
Authority
HU
Hungary
Prior art keywords
pct
pro
sec
date
derivative
Prior art date
Application number
HU912738A
Other languages
English (en)
Other versions
HU912738D0 (en
Inventor
Ulrich Kohnert
Rainer Rudolph
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HU912738D0 publication Critical patent/HU912738D0/hu
Publication of HUT59318A publication Critical patent/HUT59318A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Finger-Pressure Massage (AREA)
HU912738A 1989-12-20 1990-12-19 Process for stabilizing k2p pro t-pa HUT59318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3942141A DE3942141A1 (de) 1989-12-20 1989-12-20 K2p pro-stabilisierung

Publications (2)

Publication Number Publication Date
HU912738D0 HU912738D0 (en) 1992-01-28
HUT59318A true HUT59318A (en) 1992-05-28

Family

ID=6395924

Family Applications (2)

Application Number Title Priority Date Filing Date
HU912738A HUT59318A (en) 1989-12-20 1990-12-19 Process for stabilizing k2p pro t-pa
HU912738A HU216793B (hu) 1989-12-20 1990-12-19 Eljárás nem glikozilezett K2P pro t-PA-származékot tartalmazó gyógyszerkészítmény előállítására

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU912738A HU216793B (hu) 1989-12-20 1990-12-19 Eljárás nem glikozilezett K2P pro t-PA-származékot tartalmazó gyógyszerkészítmény előállítására

Country Status (14)

Country Link
US (1) US5352452A (hu)
EP (1) EP0458950B1 (hu)
JP (1) JPH0660108B2 (hu)
KR (1) KR920700681A (hu)
AT (1) ATE94408T1 (hu)
AU (1) AU625307B2 (hu)
CA (1) CA2046861C (hu)
DE (2) DE3942141A1 (hu)
DK (1) DK0458950T3 (hu)
ES (1) ES2060357T3 (hu)
FI (1) FI95999C (hu)
HU (2) HUT59318A (hu)
NO (1) NO305585B1 (hu)
WO (1) WO1991008765A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
ES2082465T3 (es) * 1991-04-16 1996-03-16 Boehringer Mannheim Gmbh Unidad farmaceutica de envasado que contiene activadores de plasminogeno para la administracion multiple de bolos.
WO1993022335A1 (en) * 1992-04-30 1993-11-11 Cor Therapeutics, Inc. Stable polypeptide composition
DE4405426A1 (de) * 1994-02-21 1995-08-24 Boehringer Mannheim Gmbh Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
ATE238807T1 (de) * 1997-11-07 2003-05-15 Chiron Corp Zusammensetzung um die löslichkeit von igf-i zu erhöhen
US6767892B1 (en) * 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
DK1899462T3 (da) * 2005-07-02 2011-06-06 Arecor Ltd Stabile vandige systemer omfattende proteiner
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
ATE83153T1 (de) * 1985-09-10 1992-12-15 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator
AU4187389A (en) * 1988-08-02 1990-03-05 Invitron Corporation Method for preparing tpa compositions
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942145A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa-solubilisierung
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤

Also Published As

Publication number Publication date
CA2046861A1 (en) 1991-06-21
EP0458950B1 (de) 1993-09-15
HU216793B (hu) 1999-08-30
DE59002760D1 (de) 1993-10-21
AU625307B2 (en) 1992-07-09
EP0458950A1 (de) 1991-12-04
KR920700681A (ko) 1992-08-10
JPH04503683A (ja) 1992-07-02
AU7044391A (en) 1991-07-18
ATE94408T1 (de) 1993-10-15
NO913238D0 (no) 1991-08-19
WO1991008765A1 (de) 1991-06-27
DK0458950T3 (da) 1993-12-27
US5352452A (en) 1994-10-04
FI913908A0 (fi) 1991-08-19
DE3942141A1 (de) 1991-06-27
FI95999C (fi) 1996-04-25
HU912738D0 (en) 1992-01-28
FI95999B (fi) 1996-01-15
CA2046861C (en) 2001-04-10
NO913238L (no) 1991-08-19
ES2060357T3 (es) 1994-11-16
JPH0660108B2 (ja) 1994-08-10
NO305585B1 (no) 1999-06-28

Similar Documents

Publication Publication Date Title
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
HK1075197A1 (en) New composition containing taxane derivatives as major component
AU3183389A (en) Human relaxin formulation
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
HUT59318A (en) Process for stabilizing k2p pro t-pa
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
DE3686410D1 (de) Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens.
HUT71798A (en) Process for preparing pharmaceutical compositions of antidepressant activity containing 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol)
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
AU1743088A (en) Tissue plasminogen activator analogs having modified growth factor domains
BG102553A (en) Thiol derivatives having metallopeptidase inhibitor activity
EP0695184A4 (en) HIV PROTEASE INHIBITORS
ATE103178T1 (de) T-pa pro stabilisierung.
HUT51288A (en) Process for production of derivatives of 19-substituated progesteron and medical compositions containing them
AU558461B2 (en) Carbamyloxybenzhyrol derivatives
DD155954B1 (de) Verfahren zur herstellung von n tief alpha arly-bzw. n tief alpha heteroarylsulfonylaminoacylierten amidinophenylalaninamiden
HUT59100A (en) Process for producing acetylene derivatives of calcium-absorbtion inhibiting activity and pharmaceutical compositions containing them
ES8605583A1 (es) Un procedimiento de producir un activador de plasminogeno monocatenario
HUP0102370A2 (hu) Mumbaisztatin, eljárás előállítására és alkalmazása gyógyszerhatóanyagként
ATE169021T1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel
JPS6468312A (en) Composition for oral cavity application
UA23889A (uk) Засіб для інтегральної корекції метаболічного ацид озу та алкалозу
HUT51289A (en) Process for production of derivatives of 19-fluor or zyan-21-hydroxiprogesteron and medical compositions containing them
ES2004438A6 (es) Un metodo para producir una proteina trombolitica
JPS6434922A (en) Thrombolytic agent containing water-soluble tissual plasminogen activator composition as active ingredient